NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX)
Post# of 231
(Total Views: 294)
Posted On: 02/03/2020 3:52:20 PM
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at NobleCon16 Investor Conference
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that it will present at the Noble Capital Markets 16th Annual Investor Conference. Genprex’s presentation is scheduled to take place at 1:30 p.m. EST on Monday, February 17, 2020, at the conference to be held at the Seminole Hard Rock Hotel & Casino in Hollywood, Florida from February 16-18, 2020. According to the update, Genprex CEO Rodney Varner will deliver an overview of the Company and provide updates on its product pipeline, including the Food and Drug Administration’s recent Fast Track Designation for its Oncoprex(TM) immunogene therapy in combination with AstraZeneca’s Tagrisso(R).
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that it will present at the Noble Capital Markets 16th Annual Investor Conference. Genprex’s presentation is scheduled to take place at 1:30 p.m. EST on Monday, February 17, 2020, at the conference to be held at the Seminole Hard Rock Hotel & Casino in Hollywood, Florida from February 16-18, 2020. According to the update, Genprex CEO Rodney Varner will deliver an overview of the Company and provide updates on its product pipeline, including the Food and Drug Administration’s recent Fast Track Designation for its Oncoprex(TM) immunogene therapy in combination with AstraZeneca’s Tagrisso(R).
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Genprex Inc. (GNPX) Stock Research Links
Scroll down for more posts ▼